Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ionQuick infantil is an oral rehydration therapy developed by LAINCO. Formulated according to World Health Organization (WHO) guidelines, it contains a balanced mixture of glucose and essential electrolytes (sodium, potassium, and chloride) to prevent and treat mild to moderate dehydration in children aged 3 years and older. It is indicated for fluid and electrolyte replenishment during episodes of diarrhea, vomiting, fever, intense physical activity, or extreme heat. The product is marketed as a food supplement in a convenient, ready-to-use stick format that can be taken directly, dissolved in water, or frozen.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ionQuick infantil.